Mylan recalls generic chemotherapies


The generic and specialty drug manufacturer Mylan has recalled several chemotherapy agents, including gemcitabine, carboplatin, methotrexate, and cytarabine, due to the presence of visible foreign particulates. All of the compromised medications were distributed in the United States in 2014. Outside of the recall, the month of April has seen Mylan’s shares increase by nearly 30% following a $40 billion takeover bid from Teva, the world’s largest generics manufacturer.

Read the source article at OncLive

About the Author

Leave a Reply